Antiplatelet drugs interact with platelets, which is a type of blood cell, to block platelets from aggregating into harmful clots.
An antiplatelet is a drug which destroys blood platelets.
no
antiplatelet drugs
Ibuprofen does have an antiplatelet effect, but it's relatively mild and short-lived compared to aspirin or other commonly used antiplatelet drugs.
Is that a question or statment. Please restate your question.
Yes. They both contain Clopidogrel Bisulfate (75 mg) which is an antiplatelet agent.
Mild antibacterial, mild antifungal, muscle relaxant, antiseptic, antiplatelet effects, anxiolytic.
Antiplatelet medications such as aspirin or clopidogrel (Plavix) are usually recommended. Medications may also be prescribed to lower lipoprotein levels
Siyu Liu has written: 'Antithrombotic/antiplatelet properties and mechanism of action of tetramethylpyrazine, including structure-activity relationship studies' -- subject(s): Pyridazines
It is generally safe to take aspirin and resveratrol together, but it is always best to consult with a healthcare professional before combining different medications or supplements to ensure they are safe for your specific health conditions and goals.
More correctly it is called antiplatelet aggregation drugs (also called antithrombotic drugs) that include aspirin, clopidogrel, abciximab (monoclonal antibodies) and GPII/ IIIA receptors antagonists etc. Each drug has its own way and mechanism of action. It depends upon chemical structure of drug and site of action. Aspirin blocks aggregation by inhibiting cycloxygenase that produce thromboxane A2 that causes platelet aggregation. Clopidogrel acts as antagonist to P2Y2 receptors present on platelets required for their aggregation. You can check for further details. Umar Mujahid Pharm.D u.mujahid@yahoo.com
Due to the slight risk of bleeding during or after this procedure, aspirin, aspirin-containing medications, nonsteroidal anti-inflammatory drugs, and anticoagulants and antiplatelet drugs should be withheld for at least five days before the test.
Victor L. Serebruany has written: 'Antiplatelet therapy in ACS and A-Fib' -- subject(s): Platelet Aggregation Inhibitors, Atrial Fibrillation, Therapeutic use, Blood Platelets, Physiology, Drug therapy, Acute Coronary Syndrome